‹ ›
MYP_127895
← PREVIOUS NEXT → BACK
Basic Information
FSEC
Anticancer
Antimicrobial
Toxicity / Safety ▸ Blood cell toxicity ▸ Hemolysis ▸ Hemolytic
Toxicity / Safety ▸ Cytotoxicity ▸ Cytotoxic
Wound healing/Regeneration ▸ Angiogenesis modulation ▸ Anti-angiogenic
Standard
11 amino acids
C48H77N13O21S3
Standard
Sequence
CELDENNTPMC
Physicochemical Analysis
1268.39 Da
4.05
-3.25
-3.49
-0.2957
-0.83
0.13
-0.14
-5.48
35.45
0.0000
0.00
125.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
563.84
-7.25
19.0
21.0
40.0
85.0
1.0
12.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0112112 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
SPARC-derived peptide
9606
Structure & Mods
disulfide-constrained cyclic peptide [Cyclic]
canonical L-amino-acid peptide [L]
1-11
Bio-Activity Profile
Anti-angiogenic Anticancer
HUVEC; bFGF-stimulated endothelial-cell migration
~1 pM
EC50 (bFGF-stimulated HUVEC migration assay)
PaperAnti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors PMID20525313 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/20525313/
RECORD: Rec_0127030 VERIFIED: NO
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
disulfide-constrained cyclic peptide [Cyclic]
canonical L-amino-acid peptide [L]
None
None
1-11
Bio-Activity Profile
Antimicrobial Anticancer Hemolytic
PMID11311231 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/11311231/
RECORD: Rec_0129454 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
SPARC-derived peptide
9606
Structure & Mods
disulfide-constrained cyclic peptide [Cyclic]
canonical L-amino-acid peptide [L]
1-11
Bio-Activity Profile
Anti-angiogenic Anticancer
HUVEC / neuroblastoma-endothelial context
tube formation assay
PaperAnti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors PMID20525313 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/20525313/
RECORD: Rec_0190599 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
SPARC-derived peptide
9606
Structure & Mods
disulfide-constrained cyclic peptide [Cyclic]
canonical L-amino-acid peptide [L]
1-11
Bio-Activity Profile
Anti-angiogenic Anticancer
HUVEC / neuroblastoma-endothelial context
tumor progression assay
PaperAnti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors PMID20525313 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/20525313/
RECORD: Rec_0191407 VERIFIED: NO
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Anticancer Anti-angiogenic
PaperAntiAngioPred: A Server for Prediction of Anti-Angiogenic Peptides PMID26335203 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/26335203/
1 2 NEXT LAST
Showing 5 records · Page 1 of 2